Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Cree BrianPresident | Open-market sale · 10b5-1 plan | SELL | $321K 16.2K sh | Jan 16, 2026 |
| 17 | Baumgartner FlorianEVP and CEO, Vista | Option exercise | M | — 1,026 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Ho-Sing-Loy Paul AVP, Chief Information Officer | Grant or award | A | — 1,243 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Mcdonough GeoffDirector | Option exercise | M | — 395 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $327K 4,648 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Conway Kevin JohnChief Financial Officer | Option exercise | M | — 59 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Sedor ChristianChief Accounting Officer | Tax withholding | F | $9,713 879 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | DiPerna DinoSVP Global R&D | Open-market sale · 10b5-1 plan | SELL | $622K 2,527 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 17 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $100K 19.6K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 16 | Yeh Kuanling AmyChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $34K 3,000 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 16 | Gooden NathanDirector | Grant or award | A | $67K 6,667 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 16 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $280K 600 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 15 | O'Kelly CiaranDirector | Grant or award | A | — 1,168 sh | Jan 16, 2026 traded Jan 12, 2026 |
| 15 | Hsieh Anthony LiDirector, Executive Chair, CEO & Pres., 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.10M 415.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 15 | Argen JohnDirector | Disposition to issuer | D | $297K 57.2K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 15 | Oseland Robert LChief Operating Officer | Option exercise | M | — 141.7K sh | Jan 16, 2026 traded Jan 13, 2026 |
| 15 | Oseland Robert LChief Operating Officer | Option exercise | M | — 125.0K sh | Jan 16, 2026 traded Jan 13, 2026 |
| 14 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $372K 5,427 sh | Jan 16, 2026 traded Jan 16, 2026 |
| 14 | Choudary Kiran KumarChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $968K 14.4K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 14 | Wren ChrisVP of Operations | Open-market sale | SELL | $5,529 30.0K sh | Jan 16, 2026 traded Jan 16, 2026 |
| 14 | Nithrakashyap ArvindDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $73K 1,045 sh | Jan 16, 2026 traded Jan 14, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $73K 160 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $186K 400 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $168K 360 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Edekar Edmundson TinaDirector | Option exercise | M | $12K 616 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Sims Gary LSVP & Chief Credit Officer | Grant or award | A | — 1,066 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $145K 320 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $108K 240 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Devaisher Len DPresident and COO | Grant or award | A | — 2,131 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Lee JeannieEVP, GENERAL COUNSEL | Grant or award | A | — 4,598 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Conrad Micah R.EVP & COO | Grant or award | A | — 31.5K sh | Jan 16, 2026 traded Jan 14, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $110K 240 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $73K 160 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Disposition to issuer · 10b5-1 plan | D | $513K 2,454 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Mahoney Robert JohnEVP Global Operations | Grant or award | A | — 1,734 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | D'Amico AndrewDirector | Open-market sale · 10b5-1 plan | SELL | $30K 200 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Flower JohannaDirector | Open-market sale · 10b5-1 plan | SELL | $56K 120 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Mercier MattCFO | Grant or award | A | — 6,896 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Mercier MattCFO | Grant or award | A | — 6,896 sh | Jan 16, 2026 traded Jan 15, 2026 |
| 13 | Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm | Option exercise · 10b5-1 plan | M | $513K 3,054 sh | Jan 16, 2026 traded Jan 15, 2026 |